Background: Adverse neonatal and maternal outcomes are understudied for parturients with diabetes who deliver macrosomic newborns. Objective: We hypothesized that composite-neonatal (CNAO) and maternal adverse outcomes (CMAO) would be significantly higher for individuals with diabetes macrosomic newborns. Study Design: This was a secondary analysis of APEX cohorts. The inclusion criteria were parturients with diabetes that were at least 34.0 weeks. CNAO included: Apgar score < 7 at 5 min, neonatal fracture, intracranial hemorrhage, neonatal brachial plexus palsy (NBPP), treated hypotension, or hypoxic encelopathy. CMAO included: chorioamnionitis, EBL ≥ 1,000 mL or 3rd/4th degree lacerations. Multivariate Poisson regression with robust error variance was used to calculate incidence-rate-ratios (IRR), and adjusted IRR (aIRR) Results: Among the 118,422 cohorts in APEX study, 8,410(7.5 %) had diabetes. The inclusion criteria were met by 584 (6.9 %) diabetic parturients, and among them 491 (84.0 %) delivered category I macrosomia, and 93 (16.0 %) with category II/III. The overall CNAO was 7.2 %, and it was significantly higher for parturients who delivered newborns with BW ≥ 4,500 g (15.0%) versus 4,000–4,499 g (5.7%; aIRR2.64; 95 %-CI 1.39–5.01; p: 0.006). The overall CMAO was 29.9 % and it was similar when BW ≥ 4,500 g (32.2 %) versus when BW was 4,000–4,499 (29.5 %; aIRR 1.05; 0.71–1.57). The overall rate of shoulder dystocia (SD) among macrosomic newborns was 14.7 % and it was significantly higher among those with birthweight ≥ 4,500g (28.0%) versus those with 4,000–4,449 g (12.2 %; aIRR2.21; 95 %CI 1.39–3.53). The rate of cesarean delivery did not differ between the two groups(aIRR 1.24;95 % CI 0.89–1.72). Conclusions: Among parturients with diabetes, who delivered newborns with birthweight ≥ 4,500 g versus 4,000–4,499 g, CNAO and SD were twofold higher. Thus, there is an imperative to identify newborns among individuals with diabetes whose newborn will be 4,000–4,499 versus ≥ 4,500 g.

Parturients with diabetes and associated outcomes with Macrosomic newborns / Zullo, Fabrizio; Logue, Teresa C.; Di Mascio, Daniele; Rizzo, Giuseppe; Giancotti, Antonella; Hoffman, Matthew K.; Sorrenti, Sara; Mendez Figueroa, Hector; Sciscione, Anthony C.; Fishel Bartal, Michal; Chauhan, Suneet P.. - In: EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY. - ISSN 0301-2115. - 313:(2025), pp. 1-7. [10.1016/j.ejogrb.2025.114598]

Parturients with diabetes and associated outcomes with Macrosomic newborns

Zullo, Fabrizio;Di Mascio, Daniele;Rizzo, Giuseppe;Giancotti, Antonella;Sorrenti, Sara;
2025

Abstract

Background: Adverse neonatal and maternal outcomes are understudied for parturients with diabetes who deliver macrosomic newborns. Objective: We hypothesized that composite-neonatal (CNAO) and maternal adverse outcomes (CMAO) would be significantly higher for individuals with diabetes macrosomic newborns. Study Design: This was a secondary analysis of APEX cohorts. The inclusion criteria were parturients with diabetes that were at least 34.0 weeks. CNAO included: Apgar score < 7 at 5 min, neonatal fracture, intracranial hemorrhage, neonatal brachial plexus palsy (NBPP), treated hypotension, or hypoxic encelopathy. CMAO included: chorioamnionitis, EBL ≥ 1,000 mL or 3rd/4th degree lacerations. Multivariate Poisson regression with robust error variance was used to calculate incidence-rate-ratios (IRR), and adjusted IRR (aIRR) Results: Among the 118,422 cohorts in APEX study, 8,410(7.5 %) had diabetes. The inclusion criteria were met by 584 (6.9 %) diabetic parturients, and among them 491 (84.0 %) delivered category I macrosomia, and 93 (16.0 %) with category II/III. The overall CNAO was 7.2 %, and it was significantly higher for parturients who delivered newborns with BW ≥ 4,500 g (15.0%) versus 4,000–4,499 g (5.7%; aIRR2.64; 95 %-CI 1.39–5.01; p: 0.006). The overall CMAO was 29.9 % and it was similar when BW ≥ 4,500 g (32.2 %) versus when BW was 4,000–4,499 (29.5 %; aIRR 1.05; 0.71–1.57). The overall rate of shoulder dystocia (SD) among macrosomic newborns was 14.7 % and it was significantly higher among those with birthweight ≥ 4,500g (28.0%) versus those with 4,000–4,449 g (12.2 %; aIRR2.21; 95 %CI 1.39–3.53). The rate of cesarean delivery did not differ between the two groups(aIRR 1.24;95 % CI 0.89–1.72). Conclusions: Among parturients with diabetes, who delivered newborns with birthweight ≥ 4,500 g versus 4,000–4,499 g, CNAO and SD were twofold higher. Thus, there is an imperative to identify newborns among individuals with diabetes whose newborn will be 4,000–4,499 versus ≥ 4,500 g.
2025
APEX cohort; Birthweight thresholds; Cesarean delivery; Composite outcomes; Gestational diabetes; Macrosomia complications; Maternal morbidity; Neonatal brachial plexus palsy; Perinatal outcomes; Shoulder dystocia
01 Pubblicazione su rivista::01a Articolo in rivista
Parturients with diabetes and associated outcomes with Macrosomic newborns / Zullo, Fabrizio; Logue, Teresa C.; Di Mascio, Daniele; Rizzo, Giuseppe; Giancotti, Antonella; Hoffman, Matthew K.; Sorrenti, Sara; Mendez Figueroa, Hector; Sciscione, Anthony C.; Fishel Bartal, Michal; Chauhan, Suneet P.. - In: EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY. - ISSN 0301-2115. - 313:(2025), pp. 1-7. [10.1016/j.ejogrb.2025.114598]
File allegati a questo prodotto
File Dimensione Formato  
Zullo_Parturients_2025.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.98 MB
Formato Adobe PDF
1.98 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1744005
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact